Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Lang, Brittanya | Kindy, Mark S.b; c | Kozel, F. Andrewc; d | Schultz, Susan K.c; d | Taheri, Saeidb; e; *
Affiliations: [a] Clinical Psychology Program, University of South Florida, Tampa, FL, USA | [b] Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida Tampa, FL, USA | [c] James A. Haley VA Medical Center, Tampa, FL, USA | [d] Psychiatry and Behavioral Sciences, University of South Florida, Tampa, FL, USA | [e] Byrd Alzheimer’s Institute, Tampa, FL, USA
Correspondence: [*] Correspondence to: Saeid Taheri, PhD, Department of Pharmaceutical Sciences, University of South Florida, 12901 Bruce B. Downs Blvd., MDC 30, Tampa, FL 33612, USA. Tel.: +1 813 974 7051; Fax: +1 813 974 9890; E-mail: taheris@health.usf.edu.
Abstract: Vascular cognitive impairment and dementia (VCID) is a diagnostic term applied to cognitively impaired individuals with heterogeneous cerebrovascular conditions affecting large and/or small vessels. Individual biomarkers have been identified as instrumental in relating VCID to specific underlying pathologies to better characterize this syndrome. Emerging research to refine panels of biomarkers will increase classification sensitivity and specificity. Refined VCID clustering based on the severity and pathology of vascular injury will permit the development of optimal prevention and treatment strategies. Here, we review recently reported data concerning the diversity of VCID-related pathology and attempts for VCID clustering based on biomarkers obtained from different sets of measurements. We discuss three major sets of biomarkers: 1) neuroimaging biomarkers, 2) neuropsychological performance measures, and 3) biochemical markers in current VCID clustering. Finally, we highlight the effect of blood-brain barrier health on cerebrovascular disease trajectory.
Keywords: Biomarkers, cerebrovascular diseases, clustering, neuroimaging, vascular cognitive impairment, vascular dementia
DOI: 10.3233/JAD-170733
Journal: Journal of Alzheimer's Disease, vol. 62, no. 1, pp. 39-60, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl